Hot Topics


Governments can ration access to cancer drugs, or break patent monopolies. Why is rationing so popular?:

US Industry IP memo for the TPP negotiations leaked

Knowledge Ecology International (KEI) has received a copy of U.S. industry demands on the Intellectual Property chapter of the Trans-Pacific Partnership Agreement (TPP) negotiations. A draft letter from US industry to USTR has been leaked and is available here.

Development Agenda committee mandates WIPO to examine Bolivia, Barbados, Suriname and Bangladesh prize proposals

On Friday, 26 November 2010, the 6th session of the WIPO Committee on Development Agenda and Intellectual Property approved a project entitled "Project on Open Collaborative Projects and IP-Based Models". As mentioned in KEI's previous posting on this subject, this project endeavors to implement Recommendation 36 of the Development Agenda which states:

NIH funded research involving trastuzumab (marketed by Roche under the trade name Herceptin)

13 December 2010

Drug Name(s) HERCEPTIN (Brand Name Drug)
FDA Application No. (BLA) 103792
Active Ingredient(s) TRASTUZUMAB
Company GENENTECH (Roche acquired a majority ownership in 1990, and full ownership in March 2009.)
Original Approval or Tentative Approval Date September 25, 1998

What is Herceptin? How does it work?

Statements by KEI and others on NIH rejection of Fabrazyme March-In Request

For background on the Fabrazyme case, see:

The following statements were made today by civil society on the NIH rejection of the Fabrazyme March-in Request Petition. Contact Judit Rius at if your organization would like to submit an statement.

Statement by James Love, Director of Knowledge Ecology International (KEI) (Contact: 1.202.361.3040)

Why does Bill Gates oppose discussions of a medical R&D treaty at the World Health Organization?

1. General opposition to multilateral institutions having a role in setting global norms for medical R&D
9% (22 votes)
2. Sees treaty as threat to tough global norms for intellectual property rights
29% (71 votes)
3. Thinks governments already spend too much on research to develop new medicines
2% (6 votes)
4. Both 1 & 2
47% (116 votes)
5. None of the above
12% (30 votes)
Total votes: 245

CDIP6: Bolivia's intervention on WIPO's proposed project on 'Open Collaborative Projects and IP-Based Models'

25 November 2010

The fourth day of WIPO's Committee on Development and Intellectual Property(CDIP6) has witnessed a rich discussion on how to implement Recommendation 36 of the WIPO Development Agenda which states:

Recommendation 36 (Cluster D): To exchange experiences on open collaborative projects such as the Human Genome Project as well as on intellectual property models

KEI statement to Committee on Development and Intellectual Property on WIPO project on IP and Competition Policy

Knowledge Ecology International made the following intervention today at the 6th Session of the WIPO Committee on Development and Intellectual Property (CDIP).

KEI statement to WIPO CDIP 6 on Agenda item 5

Thank you Ambassador and congratulations on your appointment as Chair of this Committee.

Revealing study by L Yager (GAO): 'Observations on efforts to quantify the economic effects of counterfeit and pirated goods'

The 6th session of the WIPO Advisory Committee on Enforcement is taking place in Geneva from 1-2 December 2010. KEI's observations on the 5th session, entitled, Positive outcome reached at WIPO Advisory Committee on Enforcement while ACTA looms in the East can be found here:

Civil Society comments on USPTO humanitarian priority review voucher proposal

On November 19, 2010, Knowledge Ecology International, Medecins Sans Frontieres/Doctors without Borders, Oxfam America and Public Citizen answered a Request for Comments from the US Department of Commerce on a proposal to "Incentivize Humanitarian Technologies and Licensing Through the Intellectual Property System".

Notes from EU Parliament meeting on innovation+access for medical technologies

Today I am attending a meeting at the European Parliament on new models of innovation for medical technologies. The event was organized by three MEPs, Thijs Berman, Eva Joly and Carl Schlyter, in collaboration with the European Parliament Working Group on Innovation, Access to Medicines and Poverity-Related Diseaes, and several consumer rights, public health and development NGOs (TACD, Health Action International, KEI, Oxfam and IQsensato).

Non-responsive letter from David Kappos of USPTO to Senators Sanders and Brown regarding ACTA consistency with US law

In a October 19, 2010, Senators Bernard Sanders (I-VT) and Sherrod Brown (D-OH) wrote to David Kappos, the Director of the USPTO, asking for an assessment of conflicts between the October 2010 ACTA text, and U.S. law. (attached here).

Undersecretary of Commerce for
Intellectual Property, David Kappos

A KEI note to Library of Congress about ACTA text

From: James Love
To: Michele Woods
Cc: Nancy Weiss
Subject: Some examples of US inconsistency with ACTA
Date: Fri, 12 Nov 2010 07:29:09 -0500

This note cites several areas where US law is plainly inconsistent with

In addition, in a separate analysis,I have called attention to proposed
legislation in USA on orphan copyrighted works that are very
inconsistent with ACTA provisions on remedies.

Some examples of inconsistencies between ACTA and US law

The November 15, 2010 version of ACTA

The final conclusions for WIPO SCCR 21

Sometime very early Saturday morning, SCCR 21 ended with these conclusions.

Communication to SCCR delegates regarding the beneficiaries of a new WIPO treaty for copyright exceptions for disabilities

Information note to SCCR delegates on the scope of disabilities in a new WIPO treaty

12 November 2010

The delegates to the SCCR are considering various proposals to deal with expanded access to copyrighted works by persons who are blind or who have other disabilities.

The proposal sponsored by Brazil, Ecuador, Mexico and Paraguay would extend the benefits of the treaty, not only to persons who are blind or visually impaired, but also as follows:

Syndicate content